SCHEMBL7190872

SCHEMBL7190872

CCCc1cc(CCC)c(OC(C)C)c(C=CC(=O)c2ccc(N)cc2)c1O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 2/20 0.41
CA2 P00918 2/20 0.41
KRAS P01116 1/20 0.41
CTSL P07711 1/20 0.40
CTSB P07858 1/20 0.40
PTPN1 P18031 1/20 0.38
CYP1B1 Q16678 1/20 0.37
CXCL12 P48061 1/20 0.36
MEN1 O00255 1/20 0.36
NPC1 O15118 1/20 0.36
ALDH1A1 P00352 1/20 0.36
LMNA P02545 1/20 0.36
MAPT P10636 1/20 0.36
NFKB1 P19838 1/20 0.36
HTT P42858 1/20 0.36
RAB9A P51151 1/20 0.36
NFKB2 Q00653 1/20 0.36
KMT2A Q03164 1/20 0.36
RELA Q04206 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7190869 1.00 CA1 (0.41) CA1CA2KRASCTSLCTSB
SCHEMBL9206910 0.92 CA1 (0.36) CA1CA2KRASCTSLCTSB
SCHEMBL9206906 0.92 CA1 (0.36) CA1CA2KRASCTSLCTSB
SCHEMBL7189632 0.91 ABCG2 (0.42) CTSLCTSBPTPN1MEN1ALDH1A1
SCHEMBL7189637 0.91 ABCG2 (0.42) CTSLCTSBPTPN1MEN1ALDH1A1
SCHEMBL7192365 0.90 CA1 (0.44) CA1CA2KRASCTSLCTSB
SCHEMBL7192362 0.90 CA1 (0.44) CA1CA2KRASCTSLCTSB
SCHEMBL9206270 0.88 ABCG2 (0.40) CTSLCTSBPTPN1MEN1ALDH1A1
SCHEMBL9206266 0.88 ABCG2 (0.40) CTSLCTSBPTPN1MEN1ALDH1A1
SCHEMBL7192349 0.88 CA1 (0.52) CA1CA2KRASCTSLCTSB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6603046-B1 The invention is drawn to novel bis-aromatic a, beta -unsaturated ketones. The compounds are useful in the treatment and prophylaxis of diseases caused by parasites or bacteria. LICA PHARMACEUTICALS A/S (DK) 2003-08-05 US disclosed
EP-0634927-B1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA LICA PHARMACEUTICALS AS (DK) 2001-07-04 EP disclosed
US-5985935-A PARASITICIDES OR BACTERICIDES STATENS SERUMINSTITUT (DK) 1999-11-16 US disclosed